Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_35836 | 33 | 0.69 | Mlig455_041101 | Neo: - Age: Up-Down-Up |
KCNMA1 | Mlig455_041101 {REF} {Length: 4124} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.6]; Ion transport protein [PF00520.33, score=67.8]; Ion channel [PF07885.18, score=59.4]; Ligand-gated ion channel [PF00060.28, score=25.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=919, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=911, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=924, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=837, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=815, Expect=0.0]} {RNA1509_44704} {RNA1310_3248} {RNA815_7829} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.351 | 1.135 | 1.00000 | 1.00000 | |
RegionR2 | -0.507 | 1.135 | 0.86906 | 1.00000 | |
RegionR3 | 0.299 | 1.135 | 0.69017 | 1.00000 | |
RegionR4 | 1.688 | 1.135 | 0.50919 | 0.83539 | |
RegionR5 | 1.517 | 1.135 | 0.42032 | 0.78042 | |
RegionR6 | 3.811 | 1.135 | 0.20489 | 0.77920 | |
RegionR7 | -2.249 | 1.135 | 1.00000 | 1.00000 | |
RegionR8 | -2.209 | 1.135 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.305 | 1.135 | 1.00000 | 1.00000 | |
RegenerationR2 | 1.874 | 1.135 | 0.48732 | 0.86643 | |
RegenerationR3 | 1.487 | 1.135 | 0.74112 | 0.96124 | |
RegenerationR4 | 1.564 | 1.135 | 0.73512 | 0.96607 | |
RegenerationR5 | -0.36 | 1.135 | 0.84381 | 1.00000 | |
RegenerationR6 | -2.445 | 1.135 | 0.39806 | 0.73605 | |
RegenerationBL | -2.239 | 1.135 | 1.00000 | 1.00000 | |
RegenerationTP | -0.488 | 1.135 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_35836 | 33 | 0.69 | Mlig455_041101 | Neo: - Age: Up-Down-Up |
KCNMA1 | 4 | 1.000 | - | 1.000 | 1.000 | 1.000 | - | Mlig455_041101 {REF} {Length: 4124} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=100.6]; Ion transport protein [PF00520.33, score=67.8]; Ion channel [PF07885.18, score=59.4]; Ligand-gated ion channel [PF00060.28, score=25.2]} {Human: ENSG00000156113, KCNMA1, potassium calcium-activated channel subfamily M alpha 1, [Score=919, Expect=0.0]} {Mouse: ENSMUSG00000063142, Kcnma1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1, [Score=911, Expect=0.0]} {Dmel: FBgn0003429, slo, slowpoke, [Score=924, Expect=0.0]} {Celegans: WBGene00004830, slo-1, Calcium-activated potassium channel slo-1, [Score=837, Expect=0.0]} {Smed: dd_Smed_v6_5509_0_1, dd_Smed_v6_5509_0_1, [Score=815, Expect=0.0]} {RNA1509_44704} {RNA1310_3248} {RNA815_7829} |
2. | MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | 1.855 | 0.960 | - | 0.895 | - | - | - | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
3. | MligTC455_33806 | 93 | 1.94 | Mlig455_009560 | Neo: - Age: Up-Down-Up Region-enriched R6: 5.229/0.00001 |
MOXD1 | 1.813 | 0.967 | - | 0.846 | - | - | - | Mlig455_009560 {REF} {Length: 2463} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=94.2]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=54.5]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=110, Expect=1e-24]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=115, Expect=1e-26]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=124, Expect=2e-29]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=134, Expect=6e-33]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=115, Expect=6e-28]} {RNA1509_32991} {RNA1310_25882} {RNA815_12058} |
4. | MligTC455_51934 | 19 | 0.39 | Mlig455_036781, Mlig455_052934 | Neo: - Age: - |
CMPK1 | 0.987 | - | - | 0.987 | - | - | - | Mlig455_036781 {REF} {Length: 2788} {Pfam: Adenylate kinase [PF00406.24, score=103.2]; AAA domain [PF13207.8, score=67.0]; AAA domain [PF13238.8, score=20.0]} {Human: ENSG00000162368, CMPK1, cytidine/uridine monophosphate kinase 1, [Score=150, Expect=3e-44]} {Mouse: ENSMUSG00000028719, Cmpk1, cytidine monophosphate (UMP-CMP) kinase 1, [Score=151, Expect=2e-44]} {Dmel: FBgn0028833, Dak1, [Score=141, Expect=9e-41]} {Celegans: WBGene00007812, C29F7.3, UMP-CMP kinase 1, [Score=133, Expect=2e-38]} {Smed: dd_Smed_v6_3353_0_1, dd_Smed_v6_3353_0_1, [Score=130, Expect=2e-37]} {RNA1509_39811} {RNA1310_32882} {RNA815_17820.1} Mlig455_052934 {REF} {Length: 2997} {Pfam: Adenylate kinase [PF00406.24, score=103.5]; AAA domain [PF13207.8, score=67.6]; AAA domain [PF13238.8, score=20.6]} {Human: ENSG00000162368, CMPK1, cytidine/uridine monophosphate kinase 1, [Score=150, Expect=3e-44]} {Mouse: ENSMUSG00000028719, Cmpk1, cytidine monophosphate (UMP-CMP) kinase 1, [Score=150, Expect=2e-44]} {Dmel: FBgn0028833, Dak1, [Score=142, Expect=4e-41]} {Celegans: WBGene00007812, C29F7.3, UMP-CMP kinase 1, [Score=134, Expect=7e-39]} {Smed: dd_Smed_v6_3353_0_1, dd_Smed_v6_3353_0_1, [Score=130, Expect=2e-37]} {RNA1509_39811} {RNA1310_32882} {RNA815_17820.1} |
5. | MligTC455_12932 | 233 | 4.86 | Mlig455_068053 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.157/0.04323 |
ANKRD40 | 0.97 | - | - | 0.970 | - | - | - | Mlig455_068053 {REF} {Length: 4350} {Pfam: OCRE domain [PF17780.3, score=45.6]; Ankyrin repeats (many copies) [PF13637.8, score=34.0]; Ankyrin repeat [PF00023.32, score=31.1]; Ankyrin repeats (3 copies) [PF12796.9, score=30.9]; Ankyrin repeats (many copies) [PF13857.8, score=25.7]; Ankyrin repeat [PF13606.8, score=19.8]} {Human: ENSG00000154945, ANKRD40, ankyrin repeat domain 40, [RH, Score=94.0, Expect=6e-20]} {Mouse: ENSMUSG00000020864, Ankrd40, ankyrin repeat domain 40, [RH, Score=93.2, Expect=7e-20]} {Dmel: FBgn0031319, CG4896, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00011270, R31.2, [RH, Score=83.6, Expect=1e-16]} {Smed: dd_Smed_v6_2392_0_2, dd_Smed_v6_2392_0_2, [Score=58.2, Expect=1e-08]} {RNA1509_49616, RNA1509_49906} {RNA1310_18118, RNA1509_49906} {RNA1509_49906, RNA815_7502} |
6. | MligTC455_16178 | 61 | 1.26 | Mlig455_066102 | Neo: - Age: - |
0.97 | - | - | 0.970 | - | - | - | Mlig455_066102 {REF} {Length: 900} {NoTransDecoderORF} {RNA1310_89375} | |
7. | MligTC455_22403 | 76 | 1.58 | Mlig455_043840, Mlig455_047410 | Neo: - Age: - |
0.969 | - | - | 0.969 | - | - | - | Mlig455_043840 {REF} {Length: 1721} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_93309} {RNA815_54296} Mlig455_047410 {REF} {Length: 1771} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_96760.2} {RNA815_54296} |
|
8. | MligTC455_18814 | 44 | 0.91 | Mlig455_001664 | Neo: - Age: Up-Down-Up |
0.967 | 0.967 | - | - | - | - | - | Mlig455_001664 {REF} {Length: 1673} {Smed: dd_Smed_v6_18585_0_1, dd_Smed_v6_18585_0_1, [Score=100, Expect=1e-23]} {RNA1310_49005} {RNA815_48672} | |
9. | MligTC455_37927 | 29 | 0.59 | Mlig455_005071, Mlig455_014052, Mlig455_025140, Mlig455_039469, Mlig455_070126 | Neo: - Age: - |
0.963 | 0.963 | - | - | - | - | - | Mlig455_005071 {REF} {Length: 965} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=28.7]; Myb/SANT-like DNA-binding domain [PF13837.8, score=20.2]} {RNA1310_46038} Mlig455_014052 {REF} {Length: 1489} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=32.8]; Myb/SANT-like DNA-binding domain [PF13837.8, score=22.5]} {RNA1310_68333} Mlig455_025140 {REF} {Length: 761} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=35.9]; Myb/SANT-like DNA-binding domain [PF13837.8, score=23.0]} {RNA1310_46038} Mlig455_039469 {REF} {Length: 1212} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=25.1]} {RNA1310_46038} {RNA815_30681} Mlig455_070126 {REF} {Length: 1489} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=32.8]; Myb/SANT-like DNA-binding domain [PF13837.8, score=22.5]} {RNA1310_68333} |
|
10. | MligTC455_32832 | 57 | 1.19 | Mlig455_011184, Mlig455_011216, Mlig455_024755 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_011184 {REF} {Length: 466} {NoTransDecoderORF} Mlig455_011216 {REF} {Length: 466} {NoTransDecoderORF} Mlig455_024755 {REF} {Length: 451} {NoTransDecoderORF} |
|
11. | MligTC455_15945 | 177 | 3.68 | Mlig455_035348, Mlig455_035389 | Neo: - Age: - |
0.959 | - | - | 0.959 | - | - | - | Mlig455_035348 {REF} {Length: 1017} {RNA1310_61723} {RNA815_54029} Mlig455_035389 {REF} {Length: 551} {NoTransDecoderORF} {RNA1310_61723} {RNA815_54029} |
|
12. | MligTC455_37096 | 119 | 2.49 | Mlig455_050902 | Neo: - Age: - Region-enriched R6: 4.558/0.00557 |
PXDN | 0.957 | 0.957 | - | - | - | - | - | Mlig455_050902 {REF} {Length: 3987} {Pfam: Animal haem peroxidase [PF03098.17, score=504.8]; Immunoglobulin domain [PF13927.8, score=48.3]; Immunoglobulin I-set domain [PF07679.18, score=46.6]; Immunoglobulin domain [PF00047.27, score=29.7]; Immunoglobulin domain [PF13895.8, score=20.9]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=452, Expect=3e-139]} {Mouse: ENSMUSG00000020674, Pxdn, peroxidasin, [Score=446, Expect=4e-138]} {Dmel: FBgn0011828, Pxn, Peroxidasin, [Score=424, Expect=6e-129]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=403, Expect=8e-123]} {Smed: dd_Smed_v6_3603_0_1, dd_Smed_v6_3603_0_1, [Score=499, Expect=7e-160]} {RNA1509_8453} {RNA1310_4027} {RNA815_967.1} |
13. | MligTC455_14860 | 14 | 0.3 | Mlig455_033599 | Neo: - Age: - |
0.954 | - | - | 0.954 | - | - | - | Mlig455_033599 {REF} {Length: 1075} {NoTransDecoderORF} {RNA1509_32111} {RNA1310_130308} {RNA815_53107.2} | |
14. | MligTC455_22799 | 44 | 0.92 | Mlig455_007721 | Neo: - Age: - |
0.953 | - | - | 0.953 | - | - | - | Mlig455_007721 {REF} {Length: 2323} {NoTransDecoderORF} {RNA1509_52931} {RNA1310_49127.1} {RNA815_30102} | |
15. | MligTC455_07822 | 103 | 2.14 | Mlig455_009973 | Neo: - Age: - Region-enriched R6: 8.220/0.00000 |
0.952 | 0.952 | - | - | - | - | - | Mlig455_009973 {REF} {Length: 1584} {RNA1310_20970} {RNA815_31710} | |
16. | MligTC455_32289 | 27 | 0.55 | Mlig455_024481 | Neo: - Age: - Region-enriched R3: 7.331/0.01209 Regeneration-upregulated R4: 7.540 Regeneration-enriched R4: 7.540 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_024481 {REF} {Length: 1359} {NoTransDecoderORF} {RNA1509_41553} {RNA1310_36966.2} {RNA815_38063.1} | |
17. | MligTC455_21661 | 46 | 0.96 | Mlig455_041318 | Neo: - Age: Down-Up-Down |
MYLK3 | 0.95 | - | - | 0.950 | - | - | - | Mlig455_041318 {REF} {Length: 2306} {Pfam: Protein kinase domain [PF00069.27, score=25.2]} {Human: ENSG00000140795, MYLK3, myosin light chain kinase 3, [Score=47.0, Expect=5e-07]} {Mouse: ENSMUSG00000031698, Mylk3, myosin light chain kinase 3, [Score=47.0, Expect=3e-07]; ENSMUSG00000051747, Ttn, titin, [Score=44.7, Expect=2e-06]} {Dmel: FBgn0265045, Strn-Mlck, Stretchin-Mlck, [Score=49.3, Expect=3e-08]} {Smed: dd_Smed_v6_8041_0_1, dd_Smed_v6_8041_0_1, [Score=47.8, Expect=6e-08]} {RNA1509_36787} {RNA1310_61258} {RNA815_10903} |
18. | MligTC455_30888 | 96 | 2 | Mlig455_058055 | Neo: - Age: logFC(26M/2M)=-0.324 |
0.95 | - | - | 0.950 | - | - | - | Mlig455_058055 {REF} {Length: 6053} {RNA1509_53360} {RNA1310_15689, RNA1509_53360} {RNA1509_53360, RNA815_1194.1} | |
19. | MligTC455_47733 | 81 | 1.69 | Mlig455_044125 | Neo: - Age: logFC(26M/2M)=0.424 Region-enriched R6: 4.050/0.00363 Regeneration-downregulated R6: -6.610 Regeneration-depleted R6: -6.610 |
0.95 | 0.950 | - | - | - | - | - | Mlig455_044125 {REF} {Length: 4219} {Pfam: Peptidase family M13 [PF05649.15, score=42.8]} {RNA1310_43623} {RNA815_36140} |